Tenaya Therapeutics to Participate at the 35th Annual Piper Sandler Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that Faraz Ali, Chief Executive Officer, will participate in the 35th Annual Piper Sandler Healthcare Conference taking place in New York, NY.
Related news for (TNYA)
- Today’s Top Performers: MoBot’s Market Review 08/18/25 12:00 PM
- Today’s Top Performers: MoBot’s Market Review 08/18/25 11:00 AM
- Breaking News: MoBot’s Latest Update as of 08/15/25 04:00 PM
- MoBot alert highlights: NASDAQ: INVZ, NASDAQ: TNYA, NASDAQ: RUN, NASDAQ: CASI, NYSE: UP (08/15/25 03:00 PM)
- Tenaya Therapeutics to Highlight Capsid Engineering, Gene Editing and Manufacturing Research at the ASGCT 28th Annual Meeting